11-Mar-2020 | Facts and Factors
Findings from Facts and Factors report “Upstream Bioprocessing Market By Product (Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactors Accessories, and Others); by Workflow (Cell Culture, Media Preparation, and Cell Separation); by Mode (Outsourced and In-house) and Regions and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global upstream bioprocessing market in 2019 was approximately USD 5.07 Billion. The market is expected to grow at a CAGR of 13.1%and is anticipated to reach around USD 11.87 Billion by 2026.
Bioprocessing refers to the use of living cells such as animal cells, bacteria, plant cells or components of these living cells such as enzymes, chloroplasts in order to get the wanted products. Upstream processing and downstream processing are main categories of bioprocessing wherein upstream bioprocessing refers to the complete processing from early cell isolation as well as cultivation to cell culture expansion till final harvest.
Research activities for the production of biosimilars/biomolecules, small therapeutic peptides, and monoclonal antibodies are driving the upstream bioprocessing market. Another major factor driving the growth of the upstream bioprocessing market is increasing the prevalence of the chronic disease across the globe.
Browse the full “Upstream Bioprocessing Market By Product (Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactors Accessories, and Others); by Workflow (Cell Culture, Media Preparation, and Cell Separation); by Mode (Outsourced and In-house) and Regions and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" report at https://www.fnfresearch.com/upstream-bioprocessing-market-by-product-cell-culture-products-697
The global upstream bioprocessing market has been segmented on the basis of product, workflow, and mode. Based on product the target market is classified as Bioreactors Accessories, Cell Culture Products, Bioreactors/Fermenters, Bags & Containers, Filters, and Others. Based upon the workflow segment the global market can be bifurcated as Cell Culture, Media Preparation, and Cell Separation.
The mode segment is classified as outsourced and In-house. The In-house mode segment is expected to account for the largest market share in terms of revenue over the forecast period. Among which outsourced segment is expected to grow at a significant rate during the forecasted year in the upstream bioprocessing industry.
Based upon the region the global upstream bioprocessing market has been classified as North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. North America is anticipated to dominate in the global upstream bioprocessing market in terms of revenue as compared to that of markets in other regions during the forecast period 2019-2026. This is attributed to the increased adoption rate of advanced technology in the countries especially in the U.S. of this region. Government funding for R&D activities is increasing which expected to propel the growth of the target market in the region.
Also, the market in the Asia Pacific is expected to grow at a considerable CAGR, owing to the presence of key operating players in the countries of the region. Latin America upstream bioprocessing market is expected to grow at a moderate pace in the coming years.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 5.07 Billion |
Projected Market Size in 2026 |
USD 11.87 Billion |
CAGR Growth Rate |
13.1% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
Thermo Fisher Scientific, Samsung BioLogics, PBS Biotech, Inc., GE Healthcare, Merck KGaA, Sartorius AG, Eppendorf AG, Applikon Biotechnology, JM BIOCONNECT, Corning, Inc., BoehringerIngelheim, CellGenix GmbH, Lonza, Patheon, CMC Biologics, and Danaher Corporation. and others. |
Key Segment |
By Product, Workflow, Mode, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Key players operating in the upstream bioprocessing market not restricted to include Thermo Fisher Scientific, Samsung BioLogics, PBS Biotech, Inc., GE Healthcare, Merck KGaA, Sartorius AG, Eppendorf AG, Applikon Biotechnology, JM BIO CONNECT, Corning, Inc., Boehringer Ingelheim, CellGenix GmbH, Lonza, Patheon, CMC Biologics, and Danaher Corporation. Companies in the global upstream bioprocessing market are focusing on organic and in-organic business strategies such as partnerships, and launches of advanced products to achieve revenue contribution in the global market.
This report segments the upstream bioprocessing market as follows:
Global Upstream Bioprocessing Market: By Product Segmentation Analysis
- Bioreactors/Fermenters
- Cell Culture Products
- Filters
- Bioreactors Accessories
- Bags & Containers
- Others
Global Upstream Bioprocessing Market: By Workflow Segmentation Analysis
- Media Preparation
- Cell Culture
- Cell Separation
Global Upstream Bioprocessing Market: By Mode Segmentation Analysis
Global Upstream Bioprocessing Market: Regional Segmentation Analysis
- North America
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
